FBLN5 and metabolic dysfunction-associated steatohepatitis: Interestingly, the expression of several hub genes (i.e., VCAN, FBLN5, and MT1M) had no difference between healthy and NAFL livers, which suggests that their alterations may be specific to the later stages of NAFLD (from NAFL to NASH).